298. 遺伝性膵炎 Hereditary pancreatitis Clinical trials / Disease details
臨床試験数 : 98 / 薬物数 : 180 - (DrugBank : 57) / 標的遺伝子数 : 53 - 標的パスウェイ数 : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05270434 (ClinicalTrials.gov) | March 1, 2022 | 10/1/2022 | Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis. | Optimal Timing of Endoscopic Intervention After Extracorporeal Shock-Wave Lithotripsy in the Treatment of Chronic Pancreatitis With Pancreatic Stones. | Pancreatitis, Chronic | Procedure: time interval between ESWL and ERCP is 12h;Procedure: time interval between ESWL and ERCP is 12-36h;Procedure: time interval between ESWL and ERCP is greater than 36h;Drug: morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics) | Changhai Hospital | NULL | Not yet recruiting | 18 Years | 75 Years | All | 225 | N/A | China |
| 2 | NCT02971475 (ClinicalTrials.gov) | November 2016 | 5/9/2016 | ESWL Versus ESWL and Endoscopic Treatment | Extracorporeal Shock Wave Lithotripsy Versus Extracorporeal Shock Wave Lithotripsy Combined With Endoscopic Treatment for Painful Calcified Chronic Pancreatitis | Pancreatitis | Procedure: extracorporeal shock wave lithotripsy;Procedure: endoscopic drainage of the main pancreatic duct;Drug: Analgesics | Changhai Hospital | NULL | Unknown status | 18 Years | N/A | All | 62 | N/A | China |